-
SOS1 inhibition enhances efficacy of KRAS G12C inhibitors in lung adenocarcinoma models
30 Jan 2025 18:03 GMT
… in approximately 13% of lung adenocarcinoma cases, are associated with limited …
-
FDA Approval of Tislelizumab Plus Chemo Offers a New Option in Advanced Gastric/GEJ Adenocarcinoma
29 Jan 2025 21:17 GMT
… or gastroesophageal junction (GEJ) adenocarcinoma, quality-of-life findings for … advanced gastric or gastroesophageal junction adenocarcinoma?
Cruz-Correa: Gastric cancer … gastric cancer or gastroesophageal junction adenocarcinoma. Front Oncol. 2024;14: …
-
FLOT Chemotherapy Improves Overall Survival in Esophageal Adenocarcinoma
27 Jan 2025 13:15 GMT
… for resectable locally advanced esophageal adenocarcinoma.
They assessed individuals with resectable … esophageal adenocarcinoma in a 1:1 … in patients with resectable esophageal adenocarcinoma.
Source: nejm.org/ …
-
Merck & Eisai provide update on phase 3 LEAP─015 trial of Keytruda plus Lenvima in combo with chemotherapy in patients with certain types of gastroesophageal adenocarcinoma
27 Jan 2025 04:40 GMT
… 2 (HER2)-negative gastroesophageal adenocarcinoma. At an interim analysis, … advanced unresectable or metastatic gastroesophageal adenocarcinoma remains a challenging disease … or gastroesophageal junction (GEJ) adenocarcinoma.
Keytruda is indicated for the …
-
Dr Spira on RMC-9805 in KRAS G12D–Mutated Pancreatic Ductal Adenocarcinoma
24 Jan 2025 21:49 GMT
… solid tumors, including pancreatic ductal adenocarcinoma.
-
Second Cancer Risk Heightened After Appendiceal Adenocarcinoma Diagnosis
24 Jan 2025 17:51 GMT
… for individuals diagnosed with appendiceal adenocarcinoma. These strategies, which include … and 20 years after appendiceal adenocarcinoma diagnosis, respectively. The cumulative … diagnosed with first primary appendiceal adenocarcinoma from 1992 to 2021. …
-
Pembrolizumab Plus Lenvatinib and Chemo Misses OS End Point in Gastroesophageal Adenocarcinoma
24 Jan 2025 16:20 GMT
… unresectable or metastatic gastroesophageal adenocarcinoma remains a challenging disease … or metastatic HER2-negative gastroesophageal adenocarcinoma.
The study was divided … with certain types of gastroesophageal adenocarcinoma. News release. Merck. January …
-
Exploring Zoldonrasib, Pan-RAS Inhibitors, and Future KRAS Therapies
30 Jan 2025 20:33 GMT
… with KRAS G12D pancreatic ductal adenocarcinoma based on preliminary findings presented …
-
Human medicines European public assessment report (EPAR): Abraxane, paclitaxel, Date of authorisation: 11/01/2008, Revision: 31, Status: Authorised
30 Jan 2025 17:24 GMT
… of the medicine.
In metastatic adenocarcinoma of the pancreas, Abraxane was …
-
Clinical Studies Conducted at Florida Cancer Specialists & Research Institute Expanding Treatment Options and Improving Outcomes for Patients with Gastrointestinal and Genitourinary Cancers
30 Jan 2025 16:42 GMT
… patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with NALIRIFOX: A …
About
© 1995-2025